查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1472131

2023-2030 年全球類器官和球體市場規模研究與預測（按類型、方法、最終用戶和區域分析）

Global Organoids and Spheroids Market Size Study & Forecast, by Type, By Method, By End-User, and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 200 Pages | 商品交期: 2-3個工作天內

價格

2022年，全球類器官和球體市場價值約為5.6051億美元，預計在2023-2030年預測期內將以超過8.5%的健康成長率成長。類器官和球體代表先進的3D (3D) 細胞培養模型，廣泛應用於科學研究，涵蓋再生醫學、藥物發現和疾病建模領域。類器官是複雜的自組織結構，由幹細胞或組織特異性祖細胞發育而來，緊密複製特定器官或組織的結構和功能。此模型源自各種細胞類型，為研究器官發育、疾病機制、藥物毒性和個人化醫療提供了一個細緻的平台。而球體是在特定培養條件下自發性形成球形的細胞聚集體。球體有助於研究廣泛源自不同細胞類型的細胞行為、藥物反應、腫瘤生物學和組織工程。類器官和球體都為研究人員提供了比傳統2D細胞培養物更生理相關的環境，並成為簡化模型和體內系統複雜性之間的重要橋樑。類器官和球體市場的推動因素包括個人化藥物需求的增加、研發活動投資的增加以及癌症研究向類器官 3D 細胞培養的轉變。 。此外，類器官技術在基因突變分析、基因評估和腫瘤建模等各種應用中的廣泛採用，將推動全球對類器官的需求。

此外，癌症、糖尿病和神經系統疾病等慢性疾病的日益普及也對全球市場的成長產生了積極影響。類器官和球體是先進的 3D 模型，可以緊密模仿人體組織結構，從而實現精確的疾病研究和治療測試。他們透過分析患者對藥物的具體反應來促進個人化藥物的開發。根據世界衛生組織 (WHO) 2021 年 4 月發布的資料，慢性病預計每年將導致 4,100 萬人死亡，相當於全球死亡人數的 71%。在低收入和中等收入國家，慢性病死亡佔77%。此外，這些模型簡化了藥物發現過程並提供了對疾病途徑的見解，有助於識別治療標靶。此外，在組織工程和再生醫學中，類器官和球體有望開發功能性組織替代品，以解決慢性疾病引起的器官損傷。整體而言，慢性病發生率的上升凸顯了類器官和球體在促進疾病理解和治療發展的重要性。此外，細胞治療和組織工程領域的不斷發展，以及 3D 球體技術的不斷進步，在預測幾年內帶來了各種利潤豐厚的機會。然而，與 3D 細胞培養相關的挑戰以及與類器官和球體培養相關的倫理問題正在阻礙 2023-2030 年預測期內的市場成長。

全球類器官和球體市場研究涵蓋的關鍵區域包括亞太地區、北美、歐洲、拉丁美洲以及中東和非洲。由於製藥和生物技術公司技術不斷進步、對生物製藥研發的關注度提高以及藥品生產和藥物發現的激增，北美將在 2022 年佔據市場主導地位。而亞太地區預計在預測年份將以最高的年複合成長率成長。 3D 細胞培養技術的進步、醫療保健支出的增加以及幹細胞研究的持續進步正在顯著推動該地區的市場需求。預計主要市場參與者之間加強合作將促進市場擴張。例如，2020 年 3 月，Nichirei Biosciences 和 UPM Biomedicals 聯手在日本提供 UPM 培養產品，從而提高了天然水凝膠用於球狀體和類器官培養的可及性。

研究的目的是確定近年來不同細分市場和國家的市場規模，並預測未來幾年的價值。該報告旨在納入參與研究的國家內該行業的定性和定量方面。

該報告還提供了有關關鍵方面的詳細資訊，例如將決定市場未來成長的促進因素和挑戰。此外，它還納入了利害關係人投資的微觀市場的潛在機會，以及對主要參與者的競爭格局和產品供應的詳細分析。

目錄

第 1 章：執行摘要

  • 市場概況
  • 2020-2030 年全球與細分市場估計與預測
    • 類器官和球體市場，按地區，2020-2030
    • 類器官和球體市場，按類型，2020-2030
    • 類器官和球體市場（依方法），2020-2030 年
    • 類器官和球體市場，按最終用戶分類，2020-2030 年
  • 主要趨勢
  • 估算方法
  • 研究假設

第 2 章：全球類器官和球體市場定義和範圍

  • 研究目的
  • 市場定義和範圍
    • 產業演變
    • 研究範圍
  • 研究涵蓋的年份
  • 貨幣兌換率

第 3 章：全球類器官與球體市場動態

  • 類器官和球體市場影響分析（2020-2030）
    • 市場促進因素
      • 慢性病盛行率增加
      • 個人化藥物的採用不斷增加
    • 市場挑戰
      • 3D 細胞培養相關的挑戰
      • 與類器官和球體培養相關的倫理問題
    • 市場機會
      • 細胞治療和組織工程領域不斷發展
      • 3D 球體技術不斷進步

第 4 章：全球類器官與球體市場產業分析

  • 波特的五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭競爭
  • 波特的五力影響分析
  • PEST分析
    • 政治的
    • 經濟
    • 社會的
    • 技術性
    • 環境的
    • 合法的
  • 頂級投資機會
  • 最佳制勝策略
  • COVID-19 影響分析
  • 顛覆性趨勢
  • 產業專家視角
  • 分析師推薦與結論

第 5 章：全球類器官和球體市場（按類型）

  • 市場概況
  • 全球類器官和球體市場（按類型、表現）-潛力分析
  • 2020-2030 年按類型分類的全球類器官和球體市場估計和預測
  • 類器官和球體市場，細分分析
    • 類器官類型
    • 球體類型

第 6 章：按方法分類的全球類器官與球體市場

  • 市場概況
  • 按方法、性能分類的全球類器官和球體市場 - 潛力分析
  • 2020-2030 年全球類器官與球體市場估計與預測（依方法）
  • 類器官和球體市場，細分分析
    • 細胞外基質支架法
    • 旋轉生物反應器法
    • 懸滴法
    • 低貼壁培養板法
    • 磁浮法

第 7 章：類器官與球體市場（依最終使用者）

  • 市場概況
  • 全球類器官和球體市場（按最終用戶、性能 - 潛力分析）
  • 2020-2030 年最終用戶全球類器官和球體市場估計和預測
  • 類器官和球體市場，細分分析
    • 生技及醫藥產業
    • 學術及研究機構
    • 醫院和診斷中心

第 8 章：全球類器官與球體市場，區域分析

  • 領先國家
  • 頂尖新興國家
  • 類器官和球體市場，區域市場概況
  • 北美洲
    • 美國
      • 2020-2030 年型別細分估計與預測
      • 2020-2030 年方法細分估計與預測
      • 2020-2030 年最終用戶細分估計與預測
    • 加拿大
  • 歐洲類器官和球體市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區類器官及球體市場概況
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲類器官與球體市場概況
    • 巴西
    • 墨西哥
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區

第 9 章：競爭情報

  • 重點企業SWOT分析
  • 頂級市場策略
  • 公司簡介
    • InSphero AG
      • 關鍵訊息
      • 概述
      • 財務（視數據可用性而定）
      • 產品概要
      • 最近的發展
    • Lonza Group
    • PeproTech Inc
    • Greiner AG
    • STEMCELL Technologies Inc
    • Corning Inc
    • Cellesce Ltd
    • Perkin Elmer Inc
    • Merck KGaA
    • Thermofisher Scientific Inc

第 10 章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場預測
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Organoids and Spheroids Market is valued at approximately USD 560.51 million in 2022 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2023-2030. Organoids and spheroids represent advanced three-dimensional (3D) cell culture models extensively employed in scientific research, spanning regenerative medicine, drug discovery, and disease modelling domains. Organoids are complex and self-organizing structures that are developed from stem cells or tissue-specific progenitor cells, closely replicating the architecture and functionality of specific organs or tissues. This model is derived from various cell types and provides a nuanced platform for investigating organ development, disease mechanisms, drug toxicity, and personalized medicine. Whereas spheroids are cell aggregates that spontaneously form spherical shapes under specific culture conditions. Spheroids are instrumental in studying cell behaviour, drug responses, tumour biology, and tissue engineering widely derived from diverse cell types. Both organoids and spheroids offer researchers more physiologically relevant environments than traditional 2D cell cultures and present as an essential bridge between simplified models and the complexities of in vivo systems. The Organoids and Spheroids Market are being driven by factors including increasing demand for personalized drugs, growing investments in R&D activities, and a rise in the shift towards organoid 3D cell cultures for cancer research. . Furthermore, the expanding adoption of organoid technology across various applications such as genetic mutation analysis, gene assessment, and tumour modelling is poised to propel the demand for organoids globally.

In addition, the increasing prevalence of chronic diseases like cancer, diabetes, and neurological disorders is also exhibiting a positive influence on market growth across the world. Organoids and spheroids, advanced 3D models, closely mimic human tissue structures, enabling precise disease studies and treatment testing. They facilitate personalized medicine development by analyzing patient-specific responses to drugs. According to World Health Organization (WHO) data published in April 2021, chronic diseases are expected to kill 41 million people each year, equivalent to 71% of all deaths globally. In low- and middle-income countries chronic disease death are accounted for 77%. Additionally, these models streamline drug discovery processes and offer insights into disease pathways, aiding in the identification of therapeutic targets. Moreover, in tissue engineering and regenerative medicine, organoids and spheroids hold promise for developing functional tissue substitutes to address organ damage caused by chronic diseases. Overall, the rising incidence of chronic diseases underscores the significance of organoids and spheroids in advancing disease understanding and treatment development. Moreover, the growing field of cell therapy and tissue engineering, as well as the increasing technological advancements in 3D spheroid technologies presents various lucrative opportunities over the forecasting years. However, the challenges associated with 3D cell culturing and ethical issues associated with organoid & spheroid cultures are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Organoids and Spheroids Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing technological advancements by pharmaceutical and biotechnology companies, a rise in focus on biopharmaceutical R&D, as well as surging production of medicines and drug discovery. Whereas Asia Pacific is expected to grow at the highest CAGR over the forecast years. The rise in advancements in 3D cell culture technology, increasing healthcare spending, and ongoing advancements in stem cell research are significantly propelling the market demand across the region. Increasing collaborations among key market players are anticipated to bolster market expansion. For instance, in March 2020, Nichirei Biosciences and UPM Biomedicals joined forces to offer UPM culture products in Japan, thus improving the accessibility of natural hydrogels for spheroid and organoid culture.

Major market players included in this report are:

  • InSphero AG
  • Lonza Group
  • PeproTech Inc.
  • Greiner AG
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Cellesce Ltd.
  • Perkin Elmer Inc.
  • Merck KGaA
  • Thermofisher Scientific Inc.

Recent Developments in the Market:

  • In August 2023, InSphero, a company renowned for its expertise in robotics and intelligent automation announced a distribution agreement with Advanced BioMatrix, a leading provider of biomaterial solutions for cellular assays and regenerative medicine. The collaboration aims to extend the application of 3D cell culture techniques beyond conventional suspension-based methods, focusing on the incorporation of scaffold-based models.
  • In June 2023, Inventia Life Science formed a strategic partnership with Biotron Healthcare to distribute its RASTRUM miniaturized 3D cell culturing platform across India. This partnership aims to enhance the field of organoids and spheroids by increasing the accessibility of the advanced technology offered by the RASTRUM platform to researchers across India.
  • in June 2023, AMSBIO launched Matrimix, a novel 3D cell culture substrate featuring a fully defined formulation and it enables researchers to grow a range of tissues. It offers a dependable and constant extracellular matrix for cell growth, this novel product should aid in the study of organoids and spheroid.

Global Organoids And Spheroids Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Type, Method, End-user, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Organoids Type
  • Spheroids Type

By Method:

  • Extracellular Matrix Scaffold Method
  • Spinning Bioreactor Method
  • Hanging Drop Method
  • Low Adherent Culture Plate Method
  • Magnetic Levitation Method

By End-user:

  • Biotechnology and Pharmaceutical Industry
  • Academic and Research Institutes
  • Hospitals and Diagnostic Centers

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1.Organoids and Spheroids Market, by Region, 2020-2030 (USD Million)
    • 1.2.2.Organoids and Spheroids Market, by Type, 2020-2030 (USD Million)
    • 1.2.3.Organoids and Spheroids Market, by Method, 2020-2030 (USD Million)
    • 1.2.4.Organoids and Spheroids Market, by End-user, 2020-2030 (USD Million)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Organoids and Spheroids Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Organoids and Spheroids Market Dynamics

  • 3.1.Organoids and Spheroids Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Increasing prevalence of chronic diseases
      • 3.1.1.2.Rising adoption of personalized medicines
    • 3.1.2.Market Challenges
      • 3.1.2.1.Challenges associated with 3D cell culturing
      • 3.1.2.2.Ethical issues associated with organoid & spheroid cultures
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Growing field of cell therapy and tissue engineering
      • 3.1.3.2.Increasing technological advancements in 3D spheroid technologies

Chapter 4.Global Organoids and Spheroids Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Organoids and Spheroids Market, by Type

  • 5.1.Market Snapshot
  • 5.2.Global Organoids and Spheroids Market by Type, Performance - Potential Analysis
  • 5.3.Global Organoids and Spheroids Market Estimates & Forecasts by Type 2020-2030 (USD Million)
  • 5.4.Organoids and Spheroids Market, Sub Segment Analysis
    • 5.4.1.Organoids Type
    • 5.4.2.Spheroids Type

Chapter 6.Global Organoids and Spheroids Market, by Method

  • 6.1.Market Snapshot
  • 6.2.Global Organoids and Spheroids Market by Method, Performance - Potential Analysis
  • 6.3.Global Organoids and Spheroids Market Estimates & Forecasts by Method 2020-2030 (USD Million)
  • 6.4.Organoids and Spheroids Market, Sub Segment Analysis
    • 6.4.1.Extracellular Matrix scaffold Method
    • 6.4.2.Spinning Bioreactor method
    • 6.4.3.Hanging Drop method
    • 6.4.4.Low adherent Culture plate method
    • 6.4.5.Magnetic leviation Method

Chapter 7.Organoids and Spheroids Market, by End-user

  • 7.1.Market Snapshot
  • 7.2.Global Organoids and Spheroids Market by End-user, Performance - Potential Analysis
  • 7.3.Global Organoids and Spheroids Market Estimates & Forecasts by End-user 2020-2030 (USD Million)
  • 7.4.Organoids and Spheroids Market, Sub Segment Analysis
    • 7.4.1.Biotechnology and Pharmaceutical Industry
    • 7.4.2.Academic and Research Institutes
    • 7.4.3.Hospitals and Diagnostic Centers

Chapter 8.Global Organoids and Spheroids Market, Regional Analysis

  • 8.1.Top Leading Countries
  • 8.2.Top Emerging Countries
  • 8.3.Organoids and Spheroids Market, Regional Market Snapshot
  • 8.4.North America Organoids and Spheroids Market
    • 8.4.1.U.S. Organoids and Spheroids Market
      • 8.4.1.1.Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2.Method breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3.End-user breakdown estimates & forecasts, 2020-2030
    • 8.4.2.Canada Organoids and Spheroids Market
  • 8.5.Europe Organoids and Spheroids Market Snapshot
    • 8.5.1.U.K. Organoids and Spheroids Market
    • 8.5.2.Germany Organoids and Spheroids Market
    • 8.5.3.France Organoids and Spheroids Market
    • 8.5.4.Spain Organoids and Spheroids Market
    • 8.5.5.Italy Organoids and Spheroids Market
    • 8.5.6.Rest of Europe Organoids and Spheroids Market
  • 8.6.Asia-Pacific Organoids and Spheroids Market Snapshot
    • 8.6.1.China Organoids and Spheroids Market
    • 8.6.2.India Organoids and Spheroids Market
    • 8.6.3.Japan Organoids and Spheroids Market
    • 8.6.4.Australia Organoids and Spheroids Market
    • 8.6.5.South Korea Organoids and Spheroids Market
    • 8.6.6.Rest of Asia Pacific Organoids and Spheroids Market
  • 8.7.Latin America Organoids and Spheroids Market Snapshot
    • 8.7.1.Brazil Organoids and Spheroids Market
    • 8.7.2.Mexico Organoids and Spheroids Market
  • 8.8.Middle East & Africa Organoids and Spheroids Market
    • 8.8.1.Saudi Arabia Organoids and Spheroids Market
    • 8.8.2.South Africa Organoids and Spheroids Market
    • 8.8.3.Rest of Middle East & Africa Organoids and Spheroids Market

Chapter 9.Competitive Intelligence

  • 9.1.Key Company SWOT Analysis
  • 9.2.Top Market Strategies
  • 9.3.Company Profiles
    • 9.3.1.InSphero AG
      • 9.3.1.1.Key Information
      • 9.3.1.2.Overview
      • 9.3.1.3.Financial (Subject to Data Availability)
      • 9.3.1.4.Product Summary
      • 9.3.1.5.Recent Developments
    • 9.3.2.Lonza Group
    • 9.3.3.PeproTech Inc
    • 9.3.4.Greiner AG
    • 9.3.5.STEMCELL Technologies Inc
    • 9.3.6.Corning Inc
    • 9.3.7.Cellesce Ltd
    • 9.3.8.Perkin Elmer Inc
    • 9.3.9.Merck KGaA
    • 9.3.10.Thermofisher Scientific Inc

Chapter 10.Research Process

  • 10.1.Research Process
    • 10.1.1.Data Mining
    • 10.1.2.Analysis
    • 10.1.3.Market Estimation
    • 10.1.4.Validation
    • 10.1.5.Publishing
  • 10.2.Research Attributes
  • 10.3.Research Assumption

LIST OF TABLES

  • TABLE 1.Global Organoids and Spheroids Market, report scope
  • TABLE 2.Global Organoids and Spheroids Market estimates & forecasts by Region 2020-2030 (USD Million)
  • TABLE 3.Global Organoids and Spheroids Market estimates & forecasts by Type 2020-2030 (USD Million)
  • TABLE 4.Global Organoids and Spheroids Market estimates & forecasts by Method 2020-2030 (USD Million)
  • TABLE 5.Global Organoids and Spheroids Market estimates & forecasts by End-user 2020-2030 (USD Million)
  • TABLE 6.Global Organoids and Spheroids Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 7.Global Organoids and Spheroids Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 8.Global Organoids and Spheroids Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 9.Global Organoids and Spheroids Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 10.Global Organoids and Spheroids Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 11.Global Organoids and Spheroids Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 12.Global Organoids and Spheroids Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 13.Global Organoids and Spheroids Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 14.Global Organoids and Spheroids Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 15.Global Organoids and Spheroids Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 16.U.S. Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 17.U.S. Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 18.U.S. Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 19.Canada Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 20.Canada Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 21.Canada Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 22.UK Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 23.UK Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 24.UK Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 25.Germany Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 26.Germany Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 27.Germany Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 28.France Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 29.France Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 30.France Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 31.Italy Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 32.Italy Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 33.Italy Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 34.Spain Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 35.Spain Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 36.Spain Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 37.RoE Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 38.RoE Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 39.RoE Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 40.China Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 41.China Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 42.China Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 43.India Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 44.India Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 45.India Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 46.Japan Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 47.Japan Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 48.Japan Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 49.South Korea Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 50.South Korea Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 51.South Korea Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 52.Australia Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 53.Australia Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 54.Australia Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 55.RoAPAC Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 56.RoAPAC Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 57.RoAPAC Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 58.Brazil Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 59.Brazil Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 60.Brazil Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 61.Mexico Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 62.Mexico Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 63.Mexico Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 64.RoLA Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 65.RoLA Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 66.RoLA Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 67.Saudi Arabia Organoids and Spheroids Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 68.South Africa Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 69.RoMEA Organoids and Spheroids Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 70.List of secondary sources, used in the study of global Organoids and Spheroids Market
  • TABLE 71.List of primary sources, used in the study of global Organoids and Spheroids Market
  • TABLE 72.Years considered for the study
  • TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1.Global Organoids and Spheroids Market, research methodology
  • FIG 2.Global Organoids and Spheroids Market, Market estimation techniques
  • FIG 3.Global Market size estimates & forecast methods
  • FIG 4.Global Organoids and Spheroids Market, key trends 2022
  • FIG 5.Global Organoids and Spheroids Market, growth prospects 2023-2030
  • FIG 6.Global Organoids and Spheroids Market, porters 5 force model
  • FIG 7.Global Organoids and Spheroids Market, pest analysis
  • FIG 8.Global Organoids and Spheroids Market, value chain analysis
  • FIG 9.Global Organoids and Spheroids Market by segment, 2020 & 2030 (USD Million)
  • FIG 10.Global Organoids and Spheroids Market by segment, 2020 & 2030 (USD Million)
  • FIG 11.Global Organoids and Spheroids Market by segment, 2020 & 2030 (USD Million)
  • FIG 12.Global Organoids and Spheroids Market by segment, 2020 & 2030 (USD Million)
  • FIG 13.Global Organoids and Spheroids Market by segment, 2020 & 2030 (USD Million)
  • FIG 14.Global Organoids and Spheroids Market, regional snapshot 2020 & 2030
  • FIG 15.North America Organoids and Spheroids Market 2020 & 2030 (USD Million)
  • FIG 16.Europe Organoids and Spheroids Market 2020 & 2030 (USD Million)
  • FIG 17.Asia Pacific Organoids and Spheroids Market 2020 & 2030 (USD Million)
  • FIG 18.Latin America Organoids and Spheroids Market 2020 & 2030 (USD Million)
  • FIG 19.Middle East & Africa Organoids and Spheroids Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable